Chris Kresser: I don’t really think we’re there yet. I think it’s much better to just base those on individual circumstances, needs, health status, all the factors that we determined. When you look at the genomic panels, you see an upregulation in this gene makes you more susceptible to diabetes, but a downregulation in that other gene makes you less susceptible, and you know, if you’re not, it really all comes down to what you’re seeing in the actual functional markers. So if someone has a higher susceptibility to diabetes, but on their current diet their fasting glucose, fasting insulin, leptin, and triglycerides and other markers that are suggestive of blood sugar function are normal, then it doesn’t really matter what the gene report says. The genes will only tell us what someone is predisposed to in terms of what might actually happen. But if it’s not happening, it’s not happening. So I don’t know how useful those panels are.